Table 3 Genetic testing performed in each group.

From: Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan

 

Period A

Period B

Number

Positive

Number

Positive

BRACAnalysis®⊠

245

25 (10.2%)

1720

188 (10.9%)

Breast cancer

180

14 (7.8%)

1288

110 (8.5%)

Ovarian cancer

65

11 (16.9%)

249

64 (25.7%)

Pancreatic cancer

0

0

112

8 (7.1%)

Prostate cancer

0

0

71

6 (8.5%)

Other genetic tests for HBOCa

132

23 (17.4%)

2

1 (50%)

Total

377

48 (12.7%)

1722

189 (11.0%)

Number per month

10.5

1.33

71.8

7.88

  1. aHereditary breast and ovarian cancer.